First administration of PB004 to animals

On June 7th, 2022, Pure Biologics commenced its first pilot preclinical study in the PB004 project developing a potential drug for the treatment of solid tumors and leukemia.

News

Inquiries

W poszukiwaniu nowych leków i przełomowych terapii – article in “Rzeczpospolita”

3 March

2021

W poszukiwaniu nowych leków i przełomowych terapii – article in “Rzeczpospolita”

An article presenting global trends in pharmaceutical R&D and how Polish companies fit into them.

European patent for modified aptamers (PB012 PureApta)

9 February

2021

European patent for modified aptamers (PB012 PureApta)

The European Patent Office issued a decision on granting a European patent for PureApta elements.

Pure Biologics’ publication in the Journal of Biomedical Science

28 January

2021

Pure Biologics’ publication in the Journal of Biomedical Science

Klaus, T., Deshmukh, S. pH-responsive antibodies for therapeutic applications. J Biomed Sci 28, 11 (2021)

PB012 PureApta on the NCBR beneficiaries’ list of successes

12 January

2021

PB012 PureApta on the NCBR beneficiaries’ list of successes

The National Center for Research and Development placed the project on the list of beneficiaries' successes.

PB001 project – the first pre-clinical panel is underway

8 January

2021

PB001 project – the first pre-clinical panel is underway

The research is carried out by Timeline Bioresearch, experienced in immuno-oncology and intestinal cancer models.

9 October

2020

First administration of PB004 to animals

W poszukiwaniu nowych leków i przełomowych terapii – article in “Rzeczpospolita”

European patent for modified aptamers (PB012 PureApta)

Pure Biologics’ publication in the Journal of Biomedical Science

PB012 PureApta on the NCBR beneficiaries’ list of successes

PB001 project – the first pre-clinical panel is underway

Zapytanie Ofertowe – PB/MAGBBRIS/0/5/20 09.10.2020

Zapytanie Ofertowe – PB/MAGBBRIS/0/4/20 17.06.2020

Zapytanie Ofertowe – PB/MAGBBRIS/0/3/20 10.04.2020

Zapytanie Ofertowe – PB/MAGBBRIS/0/2/20 25.01.2020

Zapytanie Ofertowe – PB/MAGBBRIS/0/1/20 21.01.2020